Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are aged 60 years or older
- People who have been diagnosed with mild-stage Alzheimer's disease, based on recognised medical diagnostic standards
- People whose score on a standard memory and thinking test (called the MoCA) falls between 10 and 25, which suggests enough thinking ability to take part in the training exercises
- People who are able to walk on their own or with only a small amount of help
- People who have sufficient hearing and vision to communicate during the trial
- People who are physically and mentally able to take part in training exercises that involve doing two tasks at the same time
- People who are able to provide written agreement to participate in the trial by signing a consent form
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been diagnosed with advanced-stage Alzheimer's disease, indicated by a MoCA score below 10
- People who have another condition affecting the nervous system and movement, such as Parkinson's disease, stroke, or multiple sclerosis
- People with severe hearing or vision problems that prevent them from responding to sounds or visual signals
- People with a history of psychiatric conditions, such as major depression or schizophrenia
- People with bone, joint, heart, or lung conditions that would prevent them from safely taking part in the training exercises
- People who have been taking part in another cognitive or physical rehabilitation program in the past 3 months
- People whose thinking and memory abilities have been unstable due to recent changes in their medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sümeyye AKÇAY, PhD, Fenerbahçe University
Phone: +90 542 400 25 53
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
d2 Test of Attention; Trail Making Test Part A (TMT-A); Stroop Test; Trail Making Test Part B (TMT-B):; Montreal Cognitive Assessment (MoCA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.